Gastroenterology and Hepatology

379 soru

Soru 1Soru →

A 6868-year-old woman is evaluated on hospital day 33. She was initially admitted to the intensive care unit with fever, right upper quadrant pain, jaundice, and hypotension. On admission, her temperature was 39.2∘C39.2^\circ\text{C} (102.6∘F102.6^\circ\text{F}), blood pressure was 88/54 mmHg88/54\text{ mmHg}, and heart rate was 118/min118\text{/min}. Laboratory studies showed a leukocyte count of 18,500/μL18,500/\mu\text{L}, total bilirubin of 6.2 mg/dL6.2\text{ mg/dL}, and alkaline phosphatase of 450 U/L450\text{ U/L}. She was resuscitated with intravenous fluids, started on empiric intravenous piperacillin-tazobactam, and underwent emergent endoscopic retrograde cholangiopancreatography (ERCP), which revealed purulent bile and a common bile duct stone. A biliary sphincterotomy with stone extraction was performed successfully.

Today, she is transferred to the general medical floor. She is afebrile and hemodynamically stable, and her abdominal pain has resolved. Blood cultures drawn on admission now grow *Escherichia coli*. Susceptibility testing demonstrates that the organism is resistant to ampicillin but susceptible to ceftriaxone, cefepime, ciprofloxacin, meropenem, and piperacillin-tazobactam.

Which of the following is the most appropriate next step in the pharmacotherapy of this patient?

Cevabı ve açıklamayı göster

Cevap: Switch to intravenous ceftriaxone

Cevap

The correct action is to switch to intravenous ceftriaxone.
The patient presented with severe acute ascending cholangitis, characterized by Reynolds pentad (fever, jaundice, right upper quadrant pain, hypotension, and likely altered mental status). She was appropriately managed with immediate fluid resuscitation, empiric broad-spectrum antibiotics (piperacillin-tazobactam), and emergent biliary decompression (ERCP). Following definitive source control, her condition stabilized. With blood cultures now isolating Escherichia coli susceptible to ceftriaxone, the core principle of antimicrobial stewardship requires de-escalation from broad-spectrum empiric therapy to the narrowest-spectrum effective agent. Intravenous ceftriaxone is a targeted, third-generation cephalosporin with excellent biliary penetration that is highly effective against this isolate. De-escalation minimizes the risk of adverse drug events and prevents the emergence of resistant organisms.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and initial management.
The patient had severe acute cholangitis (Reynolds pentad), was appropriately treated with empiric broad-spectrum antibiotics, and achieved complete source control via ERCP.
Establishing the patient's current clinical stability and the success of the primary intervention is required to determine the next phase of treatment.
2
Evaluate the culture and susceptibility data in the context of the patient's clinical improvement.
Blood cultures identified a single pathogen, Escherichia coli, which is susceptible to several narrower-spectrum antibiotics including ceftriaxone.
Definitive antimicrobial therapy is dictated by culture results and known sensitivities.
3
Apply the principles of antimicrobial stewardship.
De-escalate therapy from the broad-spectrum piperacillin-tazobactam to the targeted, narrow-spectrum ceftriaxone.
Narrowing therapy once sensitivities are known reduces adverse effects, limits collateral microbiome damage, and prevents antimicrobial resistance.

Anahtar Kavram

Antimicrobial stewardship dictates the de-escalation of broad-spectrum empiric antibiotics to targeted, narrow-spectrum therapy once culture and susceptibility results are available and source control is achieved.
Tahmini Süre:1m 15s
Soru 2Soru →

A 5858-year-old male is evaluated in the hospital on hospital day 33. He was initially admitted for worsening abdominal distension, lethargy, and confusion. He has a past medical history of alcoholic cirrhosis and esophageal varices. On admission, his temperature was 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), blood pressure was 105/65 mmHg105/65\text{ mmHg}, and pulse was 92/min92/\text{min}. Physical examination revealed scleral icterus, spider angiomas, a prominent fluid wave, and mild, diffuse abdominal tenderness. Laboratory studies on admission showed:

Laboratory StudyResult
Serum total bilirubin2.5 mg/dL2.5\text{ mg/dL}
Serum creatinine1.1 mg/dL1.1\text{ mg/dL}
Blood urea nitrogen22 mg/dL22\text{ mg/dL}

A diagnostic paracentesis yielded hazy fluid with a leukocyte count of 750/mm3750/\text{mm}^3 and 80%80\% polymorphonuclear cells. Due to a prolonged hospitalization for a variceal bleed one month prior, he was empirically started on intravenous piperacillin-tazobactam.

Today, his mental status has returned to baseline, and his abdominal discomfort has resolved. Ascitic fluid cultures from admission have grown *Escherichia coli*. Susceptibility testing shows the isolate is resistant to ciprofloxacin but sensitive to ceftriaxone, cefotaxime, piperacillin-tazobactam, and meropenem. Which of the following is the most appropriate next step in the pharmacologic management of this patient's infection?

Cevabı ve açıklamayı göster

Cevap: Switch therapy to intravenous ceftriaxone

Cevap

Switch therapy to intravenous ceftriaxone
The most appropriate next step is narrowing the antimicrobial regimen to intravenous ceftriaxone. This patient has spontaneous bacterial peritonitis (SBP), diagnosed by an ascitic fluid absolute neutrophil count greater than 250/mm3250/\text{mm}^3 (calculated as 750×0.80=600/mm3750 \times 0.80 = 600/\text{mm}^3). While empiric therapy with piperacillin-tazobactam was appropriately initiated due to his recent healthcare exposure, the culture results now definitively show a monomicrobial *E. coli* infection. The isolate is highly susceptible to ceftriaxone. A core principle of antimicrobial stewardship is de-escalation: once a pathogen and its susceptibilities are identified, therapy should be narrowed to the most targeted, effective agent available. Continuing broad-spectrum agents with anti-pseudomonal and anaerobic coverage (like piperacillin-tazobactam) when unnecessary promotes the development of multidrug-resistant organisms. Intravenous third-generation cephalosporins, such as ceftriaxone or cefotaxime, are the gold standard targeted therapy for acute SBP.

Adım Adım Çözüm

1
Calculate the ascitic absolute neutrophil count (ANC) to confirm the diagnosis.
ANC is 750×0.80=600/mm3750 \times 0.80 = 600/\text{mm}^3. Because this is >250/mm3> 250/\text{mm}^3, the diagnosis is spontaneous bacterial peritonitis (SBP).
Accurate diagnosis dictates the need for and duration of antibiotic therapy.
2
Evaluate the clinical response to initial empiric antibiotic therapy.
The patient's confusion and abdominal pain have resolved, indicating treatment success with empiric piperacillin-tazobactam.
Clinical stability allows the physician to safely tailor antibiotics rather than escalate.
3
Interpret the culture and susceptibility results.
The infection is caused by a monomicrobial *E. coli* isolate that is sensitive to ceftriaxone, cefotaxime, piperacillin-tazobactam, and meropenem.
Culture data allows transition from broad empiric therapy to targeted definitive therapy.
4
Apply principles of antimicrobial stewardship to select the definitive regimen.
De-escalate from the broad-spectrum piperacillin-tazobactam to the narrower-spectrum, highly effective ceftriaxone.
Narrowing the spectrum minimizes the risk of multidrug-resistant organisms and adverse effects like *C. difficile* infection while effectively treating the primary infection.

Anahtar Kavram

Antimicrobial stewardship in spontaneous bacterial peritonitis (SBP) requires de-escalation of empiric broad-spectrum antibiotics to targeted, narrow-spectrum agents (such as third-generation cephalosporins) once culture and susceptibility data become available.
Soru 3Soru →

A 74-year-old man is brought to the emergency department due to sudden-onset, severe abdominal pain that began 2 hours ago. He has a medical history of chronic obstructive pulmonary disease, heart failure with preserved ejection fraction, and paroxysmal atrial fibrillation. He recently stopped taking his prescribed apixaban. The patient reports nausea and one episode of vomiting. He also complains of mild shortness of breath. Temperature is 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure is 150/90 mmHg150/90 \text{ mmHg}, pulse is 118 /min118\text{ /min} and irregularly irregular, and respirations are 22 /min22\text{ /min}. Pulse oximetry is 94%94\% on room air. Lung auscultation reveals scattered end-expiratory wheezes. The abdomen is soft and non-distended; there is mild, diffuse tenderness to palpation, but no rebound or guarding. Bowel sounds are decreased. Laboratory studies show:

Leukocyte count: 16,500/mm316,500/\text{mm}^3
Lactic acid: 3.8 mmol/L3.8 \text{ mmol/L}
Thyroid-stimulating hormone (TSH): 0.3μU/mL0.3 \mu\text{U/mL} (N: 0.4−4.0μU/mL0.4-4.0 \mu\text{U/mL})

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Computed tomography angiography of the abdomen

Cevap

The most appropriate next step in management is computed tomography angiography of the abdomen.
The patient's presentation is highly suspicious for acute mesenteric ischemia (AMI). The classic triad of AMI includes sudden onset of severe abdominal pain, pain out of proportion to physical exam findings (e.g., severe subjective pain but a relatively soft, non-tender abdomen), and a history of an embologenic disorder (e.g., atrial fibrillation). The elevated lactic acid and leukocytosis further suggest early bowel ischemia. In a hemodynamically stable patient without frank peritonitis, the most appropriate next step in management is to confirm the diagnosis with computed tomography angiography (CTA) of the abdomen. CTA can quickly and accurately identify the location of the vascular occlusion (most commonly the superior mesenteric artery), allowing for timely intervention.

Adım Adım Çözüm

1
Analyze the clinical presentation.
The patient presents with sudden, severe abdominal pain that is out of proportion to the physical examination findings. He has an irregular pulse and a history of atrial fibrillation while off anticoagulation.
Identifying the classic 'pain out of proportion' in a patient with a high risk for arterial thromboembolism points directly to acute mesenteric ischemia.
2
Evaluate the objective laboratory data.
The laboratory results show leukocytosis and an elevated lactic acid level.
An elevated lactate in the setting of severe acute abdominal pain indicates tissue hypoperfusion and bowel ischemia, further increasing the clinical suspicion for a mesenteric vascular occlusion.
3
Determine the optimal diagnostic modality.
The patient is hemodynamically stable and does not have signs of frank peritonitis (no rebound or guarding). Therefore, imaging should be pursued before surgery.
Computed tomography angiography (CTA) of the abdomen is the gold standard and most appropriate next step to visualize the mesenteric vasculature, confirm the occlusion, and plan for potential endovascular or surgical revascularization.

Anahtar Kavram

Diagnosis of acute mesenteric ischemia
Soru 4Soru →

A 58-year-old woman is evaluated in the outpatient clinic for a six-month history of progressive abdominal bloating, frequent flatulence, and chronic watery diarrhea. She also reports a 4.5-kg (10-lb) weight loss over this period despite maintaining a normal appetite. Her past medical history is notable for Raynaud phenomenon and systemic sclerosis, for which she is taking mycophenolate mofetil. Vital signs are within normal limits. Physical examination reveals thickened, tight skin over the fingers and face, as well as mild, diffuse abdominal distension without focal tenderness or organomegaly. Laboratory studies are obtained and reveal the following:

Hemoglobin: 10.4 g/dL
Mean corpuscular volume: 106 fL
Vitamin B12: 120 pg/mL (low)
Folate: 26 ng/mL (abnormally high)

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient's gastrointestinal symptoms?

Cevabı ve açıklamayı göster

Cevap: Carbohydrate breath testing

Cevap

The correct answer is carbohydrate breath testing.
The correct answer is carbohydrate breath testing. This patient's history of systemic sclerosis puts her at high risk for intestinal dysmotility and subsequent stasis. This stasis allows colonic bacteria to migrate and overgrow in the small intestine, leading to Small Intestinal Bacterial Overgrowth (SIBO). The clinical presentation of SIBO includes bloating, flatulence, watery diarrhea, and weight loss. The classic laboratory hallmark of SIBO is a macrocytic anemia characterized by Vitamin B12 deficiency (due to bacterial consumption of dietary B12) and elevated folate levels (due to bacterial synthesis of folate). A carbohydrate breath test (using glucose or lactulose) is the most appropriate non-invasive method to confirm the diagnosis by detecting early peaks in exhaled hydrogen or methane gas.

Adım Adım Çözüm

1
Identify the patient's underlying gastrointestinal risk factor.
The patient has systemic sclerosis, which causes smooth muscle atrophy and fibrosis in the gastrointestinal tract, leading to severe intestinal dysmotility.
Recognizing the complication of dysmotility is essential, as stasis in the small bowel predisposes patients to abnormal bacterial proliferation.
2
Interpret the specific laboratory abnormalities.
The patient has a macrocytic anemia with low Vitamin B12 and abnormally high folate levels.
This unique B12/folate dichotomy is the hallmark of Small Intestinal Bacterial Overgrowth (SIBO). Enteric bacteria aggressively consume dietary Vitamin B12 while simultaneously synthesizing and secreting folate into the gut lumen.
3
Determine the optimal diagnostic study for the suspected condition.
Carbohydrate breath testing (using lactulose or glucose) is the preferred next step.
Breath testing non-invasively measures hydrogen and methane gas produced by bacterial fermentation of the ingested carbohydrate load, confirming the diagnosis of SIBO.

Anahtar Kavram

Small Intestinal Bacterial Overgrowth (SIBO) presents with malabsorption, low Vitamin B12, and high folate, frequently occurring in patients with altered intestinal motility (e.g., systemic sclerosis).

Alternatif Yöntem

While carbohydrate breath testing is the preferred non-invasive approach, the true gold standard for diagnosing SIBO is upper endoscopy with quantitative culture of a jejunal aspirate (showing >10^3 CFU/mL of bacteria). It is rarely performed due to its invasive nature.
Tahmini Süre:1m 30s
Soru 5Soru →

A 56-year-old man is admitted to the hospital with a 2-day history of diffuse abdominal pain, nausea, and progressive lethargy. He has a history of alcohol-associated cirrhosis and portal hypertension. On presentation, his temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure is 105/65 mmHg105/65\text{ mmHg}, heart rate is 98/min98/\text{min}, and respiratory rate is 20/min20/\text{min}. Physical examination shows scleral icterus, spider angiomata, and moderate abdominal distension with shifting dullness. There is diffuse abdominal tenderness but no rebound or guarding. Bowel sounds are hypoactive. Asterixis is present. Arterial blood gas analysis on room air reveals the following:

ParameterValue
pH7.317.31
pCO2\text{pCO}_231 mmHg31\text{ mmHg}
pO2\text{pO}_285 mmHg85\text{ mmHg}
HCO3−\text{HCO}_3^-15 mEq/L15\text{ mEq/L}

Diagnostic paracentesis is performed, and ascitic fluid analysis shows:

ParameterValue
Total protein1.1 g/dL1.1\text{ g/dL}
Total leukocyte count400/mm3400/\text{mm}^3
Neutrophils70%70\%
Glucose65 mg/dL65\text{ mg/dL}

Gram stain of the fluid shows no organisms.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous cefotaxime

Cevap

Intravenous cefotaxime is the most appropriate next step because the absolute neutrophil count in the ascitic fluid confirms the diagnosis of spontaneous bacterial peritonitis.
The correct answer is intravenous cefotaxime. This patient with cirrhosis presents with fever, abdominal pain, altered mental status, and a fully compensated metabolic acidosis. His ascitic fluid analysis reveals an absolute neutrophil count (ANC) of 400×0.70=280/mm3400 \times 0.70 = 280/\text{mm}^3. An ascitic fluid ANC ≥250/mm3\geq 250/\text{mm}^3 is diagnostic for spontaneous bacterial peritonitis (SBP). Because SBP is associated with high mortality, empiric antibiotic therapy must be initiated immediately after fluid collection, without waiting for culture results. The treatment of choice is a third-generation cephalosporin, such as intravenous cefotaxime or ceftriaxone, which effectively covers the most common causative organisms (e.g., Escherichia coli, Klebsiella pneumoniae, and Streptococcus pneumoniae).

Adım Adım Çözüm

1
Calculate the absolute neutrophil count (ANC) in the ascitic fluid.
The ANC is 400×0.70=280/mm3400 \times 0.70 = 280/\text{mm}^3.
An ANC ≥250/mm3\geq 250/\text{mm}^3 is the diagnostic threshold for spontaneous bacterial peritonitis (SBP).
2
Evaluate the arterial blood gas using Winter's formula to interpret the acid-base status.
Expected pCO2=1.5×15+8=30.5±2 mmHg\text{pCO}_2 = 1.5 \times 15 + 8 = 30.5 \pm 2\text{ mmHg}. Measured is 31 mmHg31\text{ mmHg}, confirming full respiratory compensation.
To rule out a superimposed respiratory acid-base disorder and determine if targeted acid-base therapy (e.g., bicarbonate) is needed.
3
Select the appropriate targeted empiric pharmacotherapy for SBP.
Intravenous cefotaxime (or ceftriaxone) should be initiated.
Third-generation cephalosporins provide optimal empiric coverage for the enteric organisms that typically cause SBP, balancing high efficacy with appropriate antibiotic stewardship.

Anahtar Kavram

Diagnosis and empiric management of Spontaneous Bacterial Peritonitis (SBP)
Soru 6Soru →

A 6565-year-old man presents to the clinic with a 33-month history of progressive difficulty swallowing both solids and liquids. He reports frequent regurgitation of undigested food, especially at night, and an unintended weight loss of 88 kg (17.617.6 lb) during this period. His medical history is significant for hypertension and a 4040-pack-year smoking history. Vital signs are within normal limits. Physical examination is unremarkable. A barium esophagram demonstrates esophageal dilation with symmetric, smooth tapering at the gastroesophageal junction. Upper gastrointestinal endoscopy shows retained food debris in the esophageal body but normal overlying mucosa; the endoscope passes easily into the stomach with gentle pressure. High-resolution esophageal manometry demonstrates absent peristalsis in the esophageal body and a high integrated relaxation pressure, indicating failure of the lower esophageal sphincter to relax upon swallowing. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Endoscopic ultrasound of the gastroesophageal junction

Cevap

Endoscopic ultrasound of the gastroesophageal junction
The patient's clinical and diagnostic findings (absent peristalsis, high integrated relaxation pressure, and a 'bird's beak' appearance) are highly indicative of an achalasia motility pattern. However, primary achalasia typically has a prolonged, indolent course in younger patients. This patient's advanced age (>60>60 years), short symptom duration (<6<6 months), profound weight loss, and significant smoking history strongly suggest pseudoachalasia. Pseudoachalasia is most commonly caused by a malignancy (e.g., gastric adenocarcinoma) infiltrating the gastroesophageal junction and myenteric plexus. Standard endoscopy often appears normal because the tumor may be submucosal or cause extrinsic compression. Therefore, the most appropriate next step is an endoscopic ultrasound (or computed tomography scan) to evaluate for a submucosal tumor before initiating definitive achalasia therapy.

Adım Adım Çözüm

1
Analyze the clinical presentation and diagnostic findings.
The patient has dysphagia to solids and liquids, a 'bird's beak' appearance on esophagram, and manometry showing absent peristalsis and incomplete lower esophageal sphincter relaxation.
To establish the primary manometric diagnosis of an achalasia-like motility disorder.
2
Evaluate the patient's demographics and history for atypical features.
The patient has advanced age (>60>60 years), rapid onset of symptoms (<6<6 months), and severe weight loss.
Primary achalasia typically presents in younger patients with an indolent course, whereas these rapid-onset red flags strongly suggest a secondary cause, known as pseudoachalasia.
3
Determine the next best diagnostic step to evaluate for secondary causes.
An endoscopic ultrasound of the gastroesophageal junction is the most appropriate next step.
Standard endoscopy can easily miss submucosal infiltrating tumors (like gastric adenocarcinoma) that cause pseudoachalasia. Endoscopic ultrasound is highly sensitive for detecting these lesions.

Anahtar Kavram

Patients presenting with an achalasia motility pattern who have clinical red flags (age >60>60 years, rapid symptom onset <6<6 months, and profound weight loss) must be evaluated for pseudoachalasia (malignancy) using endoscopic ultrasound or computed tomography before initiating definitive therapy.
Tahmini Süre:2m 30s
Soru 7Soru →

A 54-year-old woman with a long-standing history of severe alcohol use disorder is brought to the emergency department by emergency medical services after vomiting large amounts of bright red blood at home. On arrival, she is lethargic and confused. Her blood pressure is 82/50 mm Hg, and her pulse is 128/min. Physical examination reveals marked scleral icterus, multiple spider angiomas on the chest, and a visibly distended abdomen with shifting dullness. The emergency physician suspects acute variceal hemorrhage as the cause of her instability. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Establish large-bore IV access and fluid resuscitation, 2) Administer IV octreotide and prophylactic antibiotics, 3) Perform urgent EGD for variceal ligation, and 4) Evaluate for TIPS placement if the bleeding is refractory.
The algorithmic approach to suspected variceal hemorrhage prioritizes patient survival through physiological stabilization before mechanical intervention. Establishing large-bore intravenous access and administering fluids addresses the immediate, life-threatening hypovolemic shock. Vasoactive agents (octreotide) and prophylactic antibiotics (ceftriaxone) are the next most rapid and effective means to lower portal pressure and prevent infection-related mortality, respectively, and can be administered simultaneously while preparing the endoscopy suite. Endoscopy is the definitive primary treatment (via band ligation) but requires a stabilized patient. Finally, TIPS is a highly invasive salvage procedure utilized only when the aforementioned primary therapies fail to control the bleeding.

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and immediate life threats.
The patient is in hypovolemic shock (blood pressure 82/50 mm Hg, pulse 128/min) due to acute upper gastrointestinal hemorrhage.
Recognizing shock dictates that immediate life-saving stabilization (ABCs) must precede definitive diagnostic or therapeutic procedures.
2
Determine the initial medical management for suspected variceal bleeding in cirrhosis.
Vasoactive drugs (e.g., octreotide) and prophylactic antibiotics (e.g., ceftriaxone) should be administered immediately upon suspicion.
Octreotide reduces portal venous pressure to slow bleeding, and prophylactic antibiotics significantly reduce the risk of mortality and bacterial infections, which are common triggers and fatal complications of variceal bleeding.
3
Determine the timing of endoscopic and radiologic interventions.
EGD is the primary definitive treatment but is performed only after initial stabilization. TIPS is reserved strictly for treatment failure.
Performing endoscopy on an unstable patient increases the risk of cardiovascular collapse and aspiration. TIPS carries a high risk of hepatic encephalopathy and is used only as salvage therapy.

Anahtar Kavram

The management of acute variceal hemorrhage requires a strict stepwise algorithm: 1) hemodynamic stabilization, 2) pharmacotherapy with vasoactive agents and prophylactic antibiotics, 3) endoscopic intervention, and 4) salvage therapy with TIPS only for refractory cases.
Soru 8Soru →

Match each esophageal motility disorder with its most characteristic finding on high-resolution esophageal manometry.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Achalasia
Diffuse esophageal spasm
Systemic sclerosis (scleroderma) esophageal involvement
Jackhammer esophagus (hypercontractile esophagus)

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Achalasia matches with incomplete LES relaxation and absent peristalsis. Diffuse esophageal spasm matches with simultaneous contractions and normal LES relaxation. Systemic sclerosis matches with absent peristalsis and a hypotensive LES. Jackhammer esophagus matches with extremely high-amplitude coordinated contractions.
Each disorder has a unique manometric signature: Achalasia features failed LES relaxation and aperistalsis; diffuse esophageal spasm features simultaneous contractions with normal LES relaxation; systemic sclerosis features aperistalsis with a hypotensive LES; and Jackhammer esophagus features normally coordinated but extremely high-amplitude contractions.

Adım Adım Çözüm

1
Identify the core physiological defect in achalasia.
The primary issue is the loss of inhibitory neurons, which prevents the LES from relaxing upon swallowing and abolishes distal esophageal peristalsis.
This directly matches achalasia to 'incomplete LES relaxation and absent peristalsis'.
2
Differentiate diffuse esophageal spasm from other motility disorders.
It presents with uncoordinated, simultaneous contractions while normal LES function is preserved.
This matches diffuse esophageal spasm to 'simultaneous, uncoordinated, non-peristaltic contractions with normal LES relaxation'.
3
Determine the effect of systemic sclerosis on the esophagus.
Smooth muscle fibrosis affects the lower two-thirds of the esophagus, weakening the LES and abolishing peristalsis, causing severe acid reflux.
This matches systemic sclerosis to 'absent peristalsis in the lower two-thirds of the esophagus with a hypotensive LES'.
4
Identify the hallmark of Jackhammer esophagus.
It is a hypercontractile disorder characterized by intense, high-amplitude contractions that are normally coordinated.
This matches Jackhammer esophagus to 'extremely high-amplitude, prolonged, but coordinated peristaltic contractions'.

Anahtar Kavram

Diagnosis of esophageal motility disorders relies on high-resolution manometry to evaluate lower esophageal sphincter (LES) relaxation and the pattern of esophageal body peristalsis.
Tahmini Süre:1m 30s
Soru 9Soru →

A 6464-year-old man with a history of alcohol-related cirrhosis and major depressive disorder is hospitalized for worsening abdominal distension and fever. His home medications include spironolactone, furosemide, lactulose, and citalopram. On admission, his temperature is 38.138.1°C (100.6100.6°F) and blood pressure is 105/65105/65 mmHg. Physical examination reveals shifting dullness and trace bilateral pedal edema.

Diagnostic paracentesis yields ascitic fluid with a leukocyte count of 1,1001,100/mm³ (85%85\% neutrophils). Arterial blood gas analysis on room air reveals:
pH: 7.297.29
pCO 2_2: 2929 mmHg
HCO 3−_3^-: 1414 mEq/L

The patient is empirically started on intravenous piperacillin-tazobactam and vancomycin, and he receives intravenous albumin on hospital day 1. On hospital day 3, his temperature has decreased to 37.137.1°C (98.898.8°F) and his abdominal pain has resolved. The ascitic fluid culture from admission grows *Escherichia coli* that is resistant to ampicillin but susceptible to ceftriaxone, cefepime, piperacillin-tazobactam, and ciprofloxacin. Blood cultures show no growth.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Discontinue the current antibiotics and begin intravenous ceftriaxone

Cevap

Discontinue the current antibiotics and begin intravenous ceftriaxone
The correct action is to discontinue the current antibiotics and begin intravenous ceftriaxone. This patient was appropriately started on broad-spectrum empiric antibiotics for severe Spontaneous Bacterial Peritonitis (SBP). Once culture data returns showing a single organism (*E. coli*) that is susceptible to a third-generation cephalosporin, principles of antibiotic stewardship dictate that therapy must be de-escalated to the most targeted, effective, and narrow-spectrum agent available. Ceftriaxone provides excellent ascitic fluid penetration and is the standard targeted therapy for susceptible SBP.

Adım Adım Çözüm

1
Diagnose the primary condition and evaluate clinical trajectory.
The patient presented with Spontaneous Bacterial Peritonitis (SBP), evidenced by ascitic fluid neutrophils >250>250/mm³. By hospital day 3, the infection is clinically resolving.
Understanding the clinical status is required before modifying empiric life-saving therapies.
2
Interpret the culture and sensitivity data to practice antibiotic stewardship.
The culture grew *E. coli* susceptible to ceftriaxone. The current empiric regimen (piperacillin-tazobactam and vancomycin) is overly broad and should be narrowed.
De-escalating to the narrowest effective agent (ceftriaxone) reduces the risk of multi-drug resistant organism selection and antibiotic-associated complications.
3
Evaluate the arterial blood gas using Winter's formula to rule out secondary acid-base disorders.
Expected pCO 2_2 = 1.5×[HCO3−]+8±21.5 \times [\text{HCO}_3^-] + 8 \pm 2 = 1.5×14+8=29±21.5 \times 14 + 8 = 29 \pm 2. The measured pCO 2_2 is 2929 mmHg, confirming a fully compensated metabolic acidosis.
This rules out the need for aggressive acid-base interventions like sodium bicarbonate infusions, which are reserved for severe, uncompensated acidosis or specific toxicities.
4
Review the patient's home medication list for potential drug-drug interactions.
The patient takes citalopram (an SSRI). This strictly contraindicates the use of MAOIs or agents with MAOI activity, such as linezolid.
Overlooking home psychiatric medications when prescribing antibiotics can lead to fatal complications like serotonin syndrome.

Anahtar Kavram

Antibiotic Stewardship in Spontaneous Bacterial Peritonitis
Tahmini Süre:1m 30s
Soru 10Soru →

A 59-year-old man with a known history of alcohol-related cirrhosis is brought to the emergency department by his family due to increasing confusion, lethargy, and diffuse abdominal discomfort over the past 4848 hours. His home medications include nadolol, spironolactone, and furosemide. His temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), pulse is 92/min92/\text{min}, blood pressure is 105/65 mmHg105/65\text{ mmHg}, and respirations are 16/min16/\text{min}. Physical examination reveals scleral icterus and spider angiomas. The abdomen is distended with shifting dullness and diffuse, mild tenderness to palpation without rebound or guarding. Asterixis is present on neurologic examination.

Laboratory studies show the following:
TestResult
Total bilirubin3.2 mg/dL3.2\text{ mg/dL}
Albumin2.6 g/dL2.6\text{ g/dL}
INR1.61.6
Creatinine1.2 mg/dL1.2\text{ mg/dL}

A diagnostic paracentesis is performed, and ascitic fluid analysis reveals a total protein of 1.1 g/dL1.1\text{ g/dL} and a leukocyte count of 650/mm3650/\text{mm}^3 with 75%75\% neutrophils.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Intravenous ceftriaxone and intravenous albumin

Cevap

The most appropriate next step is the administration of intravenous ceftriaxone and intravenous albumin.
The correct management is administering intravenous ceftriaxone and intravenous albumin. The patient's clinical presentation of confusion, abdominal discomfort, and fever in the setting of cirrhosis strongly suggests Spontaneous Bacterial Peritonitis (SBP). The diagnosis is confirmed by an absolute neutrophil count (PMN) in the ascitic fluid of 487.5/mm3487.5/\text{mm}^3 (calculated as 650/mm3×0.75650/\text{mm}^3 \times 0.75), which is above the diagnostic threshold of 250/mm3250/\text{mm}^3. The standard of care for community-acquired SBP is a third-generation cephalosporin, such as ceftriaxone or cefotaxime, to cover enteric Gram-negative bacteria. Furthermore, intravenous albumin is indicated to decrease the risk of hepatorenal syndrome and improve survival, particularly in patients with a serum creatinine >1.0 mg/dL> 1.0\text{ mg/dL} or total bilirubin >4.0 mg/dL> 4.0\text{ mg/dL}.

Adım Adım Çözüm

1
Calculate the absolute neutrophil (PMN) count in the ascitic fluid.
650×0.75=487.5/mm3650 \times 0.75 = 487.5/\text{mm}^3.
To determine if the patient meets the diagnostic criteria for Spontaneous Bacterial Peritonitis (PMN ≥250/mm3\geq 250/\text{mm}^3).
2
Identify the required antibiotic coverage for community-acquired SBP.
A third-generation cephalosporin (e.g., ceftriaxone or cefotaxime).
SBP is typically monomicrobial and most commonly caused by enteric Gram-negative organisms like E. coli and Klebsiella, which are well covered by third-generation cephalosporins.
3
Evaluate the need for adjunctive therapy.
Intravenous albumin is indicated.
Albumin expands intravascular volume to prevent hepatorenal syndrome, which is a major cause of mortality in SBP, particularly given the patient's elevated creatinine (>1.0 mg/dL> 1.0\text{ mg/dL}) and bilirubin.

Anahtar Kavram

Diagnosis and management of Spontaneous Bacterial Peritonitis (SBP) using ascitic fluid analysis, third-generation cephalosporins, and adjunctive intravenous albumin.
Soru 11Soru →

Match each Hepatitis B (HBV) serologic and virologic profile to its corresponding clinical disease state.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

HBsAg (+), HBeAg (-), Anti-HBc IgG (+), Anti-HBs (-), HBV DNA = 250,000 IU/mL, ALT = 150 U/L
HBsAg (-), HBeAg (-), Anti-HBc IgM (+), Anti-HBs (-), HBV DNA = Undetectable, ALT = 400 U/L
HBsAg (+), HBeAg (-), Anti-HBc IgG (+), Anti-HBs (-), HBV DNA = 450 IU/mL, ALT = 22 U/L
HBsAg (-), HBeAg (-), Anti-HBc IgG (+), Anti-HBs (+), HBV DNA = Undetectable, ALT = 18 U/L
HBsAg (+), HBeAg (+), Anti-HBc IgG (+), Anti-HBs (-), HBV DNA = 5,000,000 IU/mL, ALT = 25 U/L

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The serologic patterns map specifically to phases of HBV infection based on the interplay of surface/core antigens, antibodies, and viral replication activity indicated by HBV DNA and ALT levels.
Each profile uniquely identifies a specific phase of Hepatitis B infection. Accurate matching requires recognizing the virological significance of precore mutations (HBeAg-negative but highly active), the window period (isolated core IgM), immune tolerance (high DNA, low ALT), inactive carriage (low DNA, low ALT), and resolved infection (core IgG and surface antibodies).

Adım Adım Çözüm

1
Analyze HBsAg and Anti-HBs status.
Determines active infection versus clearance/immunity.
HBsAg implies current virus presence; Anti-HBs implies clearance and acquired immunity.
2
Evaluate Anti-HBc class (IgM vs. IgG).
Differentiates acute from chronic or resolved infections.
IgM is positive during early/acute infection and the window period; IgG persists for life after initial exposure.
3
Assess viral replication and liver injury markers (HBeAg, HBV DNA, ALT) in chronic cases.
Identifies immune-tolerant, active, and inactive states.
High DNA with normal ALT indicates tolerance; High DNA with high ALT indicates active hepatitis; Low DNA with normal ALT indicates an inactive carrier.

Anahtar Kavram

Hepatitis B Serology and Disease Phases
Soru 12Soru →

A 6868-year-old man is evaluated on postoperative day 55 following a partial colectomy for recurrent uncomplicated diverticulitis. Over the past 2424 hours, he has developed a fever, tachycardia, and new-onset copious, watery diarrhea. He reports mild, diffuse abdominal cramping but no nausea or vomiting. His current medications include intravenous fluids, prophylactic subcutaneous enoxaparin, and patient-controlled analgesia. He received a standard course of perioperative intravenous cefoxitin. His temperature is 38.6∘C38.6^\circ\text{C} (101.5∘F101.5^\circ\text{F}), blood pressure is 118/74 mm Hg118/74 \text{ mm Hg}, and pulse is 112/min112/\text{min}. On physical examination, the abdomen is mildly distended and diffusely tender to deep palpation, without rigidity or rebound tenderness. The surgical incision is clean, dry, and intact.

Laboratory studies show:
Leukocyte count: 18,500/mm318,500/\text{mm}^3

Arterial blood gas (room air):
pH: 7.327.32
pCO 2_2: 30 mm Hg30 \text{ mm Hg}
HCO 3−_3^-: 15 mEq/L15 \text{ mEq/L}

A stool enzyme immunoassay (EIA) is positive for *Clostridioides difficile* toxins A and B.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate oral vancomycin

Cevap

Initiate oral vancomycin therapy to treat the Clostridioides difficile infection directly within the gut lumen.
This patient has developed a hospital-acquired *Clostridioides difficile* infection (CDI), supported by the classic presentation of fever, leukocytosis, and copious watery diarrhea following recent antibiotic exposure. The correct management for a first episode of non-fulminant CDI is a 1010-day course of oral vancomycin or oral fidaxomicin. Because *C. difficile* causes disease strictly within the colonic lumen, the chosen antibiotic must achieve high intraluminal concentrations. Oral vancomycin is not absorbed systemically, allowing it to act locally on the colonic mucosa to eradicate the pathogen.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and timeline.
The patient has fever, leukocytosis, and watery diarrhea on postoperative day 5 after receiving perioperative antibiotics.
Establishing the postoperative timeline helps rule out early causes of fever (like atelectasis) and points toward infection, particularly antibiotic-associated diarrhea.
2
Interpret the diagnostic test results.
The stool EIA is positive for C. difficile toxins A and B, confirming the diagnosis of Clostridioides difficile infection (CDI).
A positive toxin assay in the setting of compatible clinical symptoms establishes the indication for targeted pharmacotherapy.
3
Evaluate the arterial blood gas (ABG) values.
The patient has a metabolic acidosis (pH 7.32, HCO3- 15). Using Winter's formula, Expected pCO2 = (1.5 × 15) + 8 = 30.5 ± 2. The measured pCO2 is 30, indicating appropriate respiratory compensation.
Ruling out a superimposed primary respiratory disorder or uncompensated state ensures that systemic metabolic interventions (like sodium bicarbonate) are withheld appropriately.
4
Determine the optimal pharmacologic management.
Oral vancomycin or oral fidaxomicin is the preferred first-line therapy.
The medication must reach the colonic lumen; intravenous vancomycin is not secreted into the bowel and is ineffective for CDI.

Anahtar Kavram

The first-line treatment for an initial, non-fulminant episode of Clostridioides difficile infection is oral vancomycin or oral fidaxomicin; intravenous vancomycin is ineffective because it does not cross the gut mucosa.
Tahmini Süre:1m 15s
Soru 13Soru →

During bedside rounds on the medical-surgical ward, a clinical team evaluates a patient on hospital day 44. The patient was initially admitted for severe acute pancreatitis secondary to cholelithiasis. Despite adequate initial volume resuscitation, the patient has required continuous nasojejunal enteral nutrition and aggressive pain management for unremitting epigastric discomfort.

Vital signs demonstrate a temperature of 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), a heart rate of 112/min112\text{/min}, respirations of 18/min18\text{/min}, and a blood pressure of 116/72 mm Hg116/72\text{ mm Hg}.

Physical examination reveals a distended abdomen with marked epigastric tenderness. Bowel sounds are hypoactive. No scleral icterus is present.

Laboratory analysis shows:
Leukocyte count: 15,800/mm315,800\text{/mm}^3
Hemoglobin: 14.2 g/dL14.2\text{ g/dL}
Blood urea nitrogen: 28 mg/dL28\text{ mg/dL}
Total bilirubin: 0.9 mg/dL0.9\text{ mg/dL} (decreased from 3.2 mg/dL3.2\text{ mg/dL} on admission)
Alkaline phosphatase: 110 U/L110\text{ U/L} (decreased from 340 U/L340\text{ U/L} on admission)
Alanine aminotransferase (ALT): 45 U/L45\text{ U/L} (decreased from 450 U/L450\text{ U/L} on admission)

Due to the persistent systemic inflammatory response syndrome (SIRS) and severe pain, a contrast-enhanced computed tomography (CT) scan of the abdomen is obtained. The imaging demonstrates diffuse pancreatic enlargement with interstitial edema and >30%>30\% non-enhancement of the pancreatic parenchyma, consistent with acute necrotizing pancreatitis. Several acute peripancreatic fluid collections are noted. There is no evidence of retroperitoneal gas or pneumobilia.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Continue current supportive management

Cevap

Continue current supportive management
The correct management for this patient is to continue current supportive care. The patient has developed acute necrotizing pancreatitis, a severe complication of gallstone pancreatitis. In the first 1 to 2 weeks of illness, patients with extensive pancreatic necrosis frequently develop Systemic Inflammatory Response Syndrome (SIRS), presenting with fever, tachycardia, and leukocytosis. This is driven by massive cytokine release from the necrotic tissue, not necessarily an active bacterial infection. Because the CT scan shows no evidence of gas within the fluid collections (the hallmark of infected necrosis), this patient's necrosis is considered sterile. Current clinical guidelines strongly recommend against the use of prophylactic antibiotics in sterile pancreatic necrosis. The mainstay of therapy remains aggressive supportive care, including continued enteral nutrition (which helps maintain the gut mucosal barrier and prevents bacterial translocation), fluid management, and analgesia.

Adım Adım Çözüm

1
Analyze the clinical presentation and timeline.
The patient has severe acute pancreatitis on hospital day 4, displaying criteria for Systemic Inflammatory Response Syndrome (SIRS) including fever, tachycardia, and leukocytosis.
Establishing the timeline is critical, as SIRS is an expected physiologic response to early tissue necrosis, whereas true infected necrosis typically develops late (after 10-14 days).
2
Interpret the diagnostic imaging findings.
The CT scan confirms >30% pancreatic necrosis. Crucially, there is no retroperitoneal gas visualized.
The presence of gas within the necrotic collection is the pathognomonic radiological sign of infected pancreatic necrosis. Its absence strongly suggests the necrosis is currently sterile.
3
Evaluate the laboratory trends for biliary obstruction.
Total bilirubin, alkaline phosphatase, and ALT have normalized since admission.
Normalizing liver chemistries confirm that the initial inciting gallstone has spontaneously passed, ruling out ongoing biliary obstruction or concurrent ascending cholangitis.
4
Determine the appropriate intervention based on current guidelines.
Select continued supportive care (enteral feeding, hydration, pain control).
Current gastroenterology guidelines strongly advise against prophylactic antibiotics or early surgical/procedural interventions for sterile necrotizing pancreatitis, focusing strictly on supportive critical care.

Anahtar Kavram

Management of sterile pancreatic necrosis and antibiotic stewardship in acute pancreatitis
Tahmini Süre:2m 0s
Soru 14Soru →

Match each esophageal disorder with its most characteristic diagnostic finding on imaging or endoscopy.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Achalasia
Diffuse esophageal spasm
Eosinophilic esophagitis
Zenker diverticulum

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Achalasia matches with "Bird's beak" tapering; Diffuse esophageal spasm matches with "Corkscrew" pattern; Eosinophilic esophagitis matches with multiple corrugated rings; Zenker diverticulum matches with posterior mucosal outpouching.
Each esophageal disorder has a highly specific anatomic or functional abnormality that produces characteristic findings. Achalasia's impaired lower esophageal sphincter relaxation produces a smooth distal tapering ("bird's beak"). Diffuse esophageal spasm's uncoordinated contractions produce a "corkscrew" shape. Eosinophilic esophagitis causes chronic mucosal changes that appear as concentric rings. Zenker diverticulum is a direct structural herniation (false diverticulum) at Killian triangle.

Adım Adım Çözüm

1
Recall the primary mechanism and imaging finding for Achalasia.
Failure of lower esophageal sphincter relaxation results in a "bird's beak" tapering.
This is a direct application of classic illness scripts for esophageal disorders.
2
Recall the primary mechanism and imaging finding for Diffuse esophageal spasm.
Uncoordinated contractions create a "corkscrew" appearance.
Simultaneous contractions segment the barium column on fluoroscopy.
3
Recall the classic endoscopic finding for Eosinophilic esophagitis.
Mucosal remodeling leading to "trachealization" or corrugated rings.
Chronic allergic inflammation leads to structural changes in the esophageal mucosa.
4
Recall the anatomic location and definition of Zenker diverticulum.
A posterior mucosal outpouching through Killian triangle.
This false diverticulum forms due to elevated intraluminal pressures above the upper esophageal sphincter.

Anahtar Kavram

Recognizing the classic imaging and endoscopic findings for esophageal structural and motility disorders.
Soru 15Soru →

A 28-year-old man comes to the clinic reporting a 2-day history of watery, non-bloody diarrhea. He reports passing 4 to 5 loose bowel movements per day, accompanied by mild, diffuse abdominal cramping. He denies having any fever, nausea, vomiting, or recent travel history. He has no significant past medical history, takes no medications, and has had no recent sick contacts. Vital signs include a temperature of 37.1°C (98.8°F), blood pressure of 118/76 mmHg, pulse of 82/min, and respiratory rate of 14/min. Physical examination reveals a soft, non-distended abdomen with mild diffuse tenderness and hyperactive bowel sounds. There is no rebound tenderness or guarding. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Reassurance and oral rehydration therapy

Cevap

Reassurance and oral rehydration therapy is the most appropriate next step.
This patient's presentation of acute, watery, non-bloody diarrhea with mild cramping and normal vital signs is highly characteristic of acute viral gastroenteritis. In the absence of 'red flag' symptoms such as high fever, severe abdominal pain, bloody stools, or signs of severe volume depletion, diagnostic testing (like stool cultures) and antibiotic therapy are not indicated. The cornerstone of management for uncomplicated acute diarrhea is supportive care, primarily focusing on fluid and electrolyte replacement with oral rehydration therapy. This condition is self-limiting and typically resolves within a few days without any pharmacological intervention.

Adım Adım Çözüm

1
Evaluate the patient's clinical presentation and vital signs.
The patient has acute, non-bloody diarrhea with stable vital signs, no high fever, and a benign abdominal examination.
To distinguish between uncomplicated gastroenteritis and severe or invasive disease that might require further diagnostic workup.
2
Determine the need for diagnostic testing or empiric antibiotics.
Given the complete absence of 'red flag' symptoms (e.g., bloody stools, high fever, severe focal pain, signs of volume depletion), diagnostic testing and antibiotics are unnecessary.
Most cases of acute diarrhea are viral in etiology. Antibiotics do not alter the clinical course of viral gastroenteritis and can lead to adverse effects or resistance.
3
Select the appropriate management strategy.
Supportive care with oral rehydration therapy is chosen as the definitive plan.
This is the gold standard of care for acute, uncomplicated diarrhea to prevent dehydration while the illness self-resolves.

Anahtar Kavram

The management of acute uncomplicated diarrhea involves supportive care and oral rehydration, avoiding unnecessary empiric antibiotics to adhere to proper antimicrobial stewardship.
Tahmini Süre:1m 0s
Soru 16Soru →

Identify the defining serologic or biochemical marker that is most specific for diagnosing each of the following hepatobiliary conditions.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Primary biliary cholangitis
Primary sclerosing cholangitis
Autoimmune hepatitis
Hereditary hemochromatosis

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Primary biliary cholangitis matches with anti-mitochondrial antibodies. Primary sclerosing cholangitis matches with p-ANCA. Autoimmune hepatitis matches with anti-smooth muscle antibodies. Hereditary hemochromatosis matches with elevated transferrin saturation and HFE gene mutation.
Each hepatobiliary disorder has a distinct pathophysiologic signature. Primary biliary cholangitis specifically targets intrahepatic ducts and is AMA-positive. Primary sclerosing cholangitis targets the entire biliary tree, causes stricturing, and is often p-ANCA positive. Autoimmune hepatitis is hepatocellular and ASMA-positive. Hereditary hemochromatosis is an iron metabolism disorder identified by high transferrin saturation and confirmed by HFE genotyping.

Adım Adım Çözüm

1
Analyze the serologic profile of primary biliary cholangitis.
Matches with anti-mitochondrial antibodies (AMA).
AMA is highly sensitive and specific (over 90%) for primary biliary cholangitis, an autoimmune destruction of small intrahepatic bile ducts.
2
Analyze the profile for primary sclerosing cholangitis.
Matches with p-ANCA and biliary stricturing.
Primary sclerosing cholangitis involves inflammation and fibrosis of both intra- and extrahepatic bile ducts (causing strictures) and is frequently p-ANCA positive due to its strong association with inflammatory bowel disease.
3
Analyze the serologic profile for autoimmune hepatitis.
Matches with anti-smooth muscle antibodies (ASMA).
Classic (Type 1) autoimmune hepatitis is driven by autoantibodies against smooth muscle and nuclei, presenting with elevated IgG and hepatocellular inflammation.
4
Analyze the biochemical profile for hereditary hemochromatosis.
Matches with elevated transferrin saturation and HFE gene mutation.
The pathogenesis of hemochromatosis involves abnormal iron sensing due to HFE mutations, leading to iron overload that is typically screened via elevated transferrin saturation.

Anahtar Kavram

Autoantibodies and biochemical markers in hepatobiliary diseases
Tahmini Süre:45s
Soru 17Soru →

A 68-year-old man is hospitalized for community-acquired pneumonia and treated with intravenous ceftriaxone and azithromycin. On day 5 of his admission, he develops new-onset frequent, watery diarrhea, mild diffuse abdominal pain, and a temperature of 38.2°C (100.8°F). His vital signs are otherwise stable, and physical examination reveals mild lower abdominal tenderness without rebound or guarding. The medical team suspects an infectious complication related to his recent pharmacotherapy. Arrange the following management steps in the most appropriate chronological sequence for addressing this new complication.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Implementation of enteric contact precautions, followed by discontinuation of the current antibiotics, then submission of a stool sample for testing, and finally initiation of targeted oral antimicrobial therapy.
This patient has developed classic signs of Clostridioides difficile infection (CDI) following a course of broad-spectrum antibiotics for pneumonia. The chronological management algorithm in the inpatient setting must balance patient care with infection control and antibiotic stewardship. The very first action upon suspecting CDI must be the implementation of enteric contact precautions (including the use of gowns, gloves, and handwashing with soap and water) to prevent the dissemination of highly resilient spores to other patients. The next immediate step is to discontinue the offending antibiotics, if clinically feasible, as this alone can resolve mild CDI and is essential for allowing the normal gut microbiome to recover. Following these initial measures, a sample of the abnormal stool should be sent for confirmatory testing (e.g., NAAT/PCR or toxin EIA). Finally, once the diagnosis is confirmed (or if the patient were hemodynamically unstable, which this patient is not), targeted therapy with an appropriate agent such as oral fidaxomicin or oral vancomycin is initiated.

Adım Adım Çözüm

1
Prevent healthcare-associated transmission.
Implement enteric contact precautions immediately.
When Clostridioides difficile infection is suspected in a hospitalized patient, isolation is the most urgent priority to protect other vulnerable patients from spore transmission.
2
Address the underlying pharmacological trigger.
Discontinue the offending antibiotics (ceftriaxone and azithromycin).
Continuing broad-spectrum antibiotics perpetuates the gut flora disruption that allows the pathogen to thrive. Stopping them is a critical early step.
3
Confirm the clinical suspicion.
Submit a watery stool sample for diagnostic testing.
Empiric treatment for stable patients should be avoided until diagnostic confirmation is achieved, ensuring that targeted therapy is truly indicated.
4
Treat the established infection.
Initiate oral fidaxomicin or oral vancomycin.
Once the diagnosis is supported by laboratory evidence, specific antimicrobial therapy against the pathogen is started to eradicate the infection.

Anahtar Kavram

The management of suspected hospital-acquired Clostridioides difficile infection prioritizes immediate infection control, followed by discontinuation of the inciting agent, diagnostic confirmation, and finally targeted oral therapy.
Soru 18Soru →

An inpatient medical team is evaluating a 62-year-old man with a known history of decompensated alcohol-associated cirrhosis who developed worsening confusion and lethargy over the past 24 hours. He has a past medical history of chronic obstructive pulmonary disease. His wife, who is his legally appointed healthcare proxy, is at the bedside; his estranged son is also present and frequently interrupts the care team to demand interventions. Vital signs are within normal limits. Physical examination reveals scleral icterus, a moderately distended abdomen with shifting dullness, and a coarse, flapping tremor of the hands when the wrists are extended. Laboratory evaluation demonstrates an elevated serum ammonia level, a normal thyroid-stimulating hormone level with a slightly decreased free T4, and a urinalysis showing >105>10^5 colony-forming units/mL of Escherichia coli without leukocyte esterase or nitrites. The patient denies dysuria or urinary frequency. An arterial blood gas reveals a normal partial pressure of carbon dioxide. The son demands that the team immediately insert a feeding tube to provide nutrition. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administration of oral or rectal lactulose

Cevap

Administration of oral or rectal lactulose
The correct answer addresses the patient's primary acute issue: hepatic encephalopathy. The patient exhibits classic clinical signs, including altered mental status and asterixis, in the setting of decompensated cirrhosis. The first-line treatment is lactulose. Lactulose lowers the colonic pH, which facilitates the conversion of absorbable ammonia (NH3NH_3) into nonabsorbable ammonium (NH4+NH_4^+). This traps the toxin in the gut lumen, allowing it to be excreted, thereby rapidly improving the patient's neurological status.

Adım Adım Çözüm

1
Analyze the patient's core clinical presentation and physical exam findings.
The patient has known cirrhosis and presents with new-onset lethargy, confusion, and asterixis (flapping tremor).
Identifying the primary syndrome is necessary to determine the appropriate targeted therapy.
2
Correlate clinical findings with laboratory data.
Elevated serum ammonia confirms the clinical suspicion of hepatic encephalopathy.
Ammonia accumulates in advanced liver disease due to impaired hepatic clearance, crossing the blood-brain barrier and causing neurotoxicity.
3
Determine the first-line pharmacological treatment for the diagnosed condition.
Lactulose is selected as the optimal initial therapy.
Lactulose is a nonabsorbable disaccharide that lowers colonic pH, converting ammonia to nonabsorbable ammonium and promoting its excretion in feces.

Anahtar Kavram

Diagnosis and acute management of hepatic encephalopathy.
Soru 19Soru →

A 68-year-old woman is evaluated in the hospital on day 3 of admission for acute cholangitis. She initially presented with fever, right upper quadrant pain, and jaundice. She was started on empiric intravenous piperacillin-tazobactam and successfully underwent endoscopic retrograde cholangiopancreatography with biliary stone extraction.

Currently, she is afebrile and her abdominal pain has entirely resolved. Blood and bile cultures obtained on admission both grow *Klebsiella pneumoniae*. The antimicrobial susceptibility report is as follows:

AntimicrobialSusceptibility
AmpicillinResistant
CeftriaxoneSusceptible
CiprofloxacinSusceptible
MeropenemSusceptible
Piperacillin-tazobactamSusceptible

Which of the following is the most appropriate next step in the patient's pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Transition to intravenous ceftriaxone

Cevap

Transition to intravenous ceftriaxone.
Ceftriaxone is the most appropriate choice because it provides targeted, narrow-spectrum coverage against the susceptible *Klebsiella pneumoniae* isolate. Antimicrobial stewardship guidelines strongly recommend de-escalating from broad-spectrum empiric therapy (like piperacillin-tazobactam) to a narrower-spectrum agent once culture and susceptibility data become available and the patient is clinically stable.

Adım Adım Çözüm

1
Assess the patient's clinical status and review the finalized culture and susceptibility testing.
The patient is clinically stable, and cultures show *Klebsiella pneumoniae* susceptible to multiple agents, including narrow-spectrum options.
Clinical improvement indicates it is safe to transition from empiric broad-spectrum therapy to targeted therapy.
2
Select the most narrow-spectrum, effective antimicrobial agent based on the susceptibility profile.
Ceftriaxone is chosen over the broader piperacillin-tazobactam and meropenem.
Antimicrobial stewardship dictates de-escalating to the narrowest effective agent to prevent the development of multidrug-resistant organisms.

Anahtar Kavram

Antimicrobial stewardship and de-escalation of empiric antibiotics based on culture results.
Tahmini Süre:1m 0s
Soru 20Soru →

During morning rounds, the care team reviews the chart of a 71-year-old woman who is currently receiving inpatient treatment for acute ascending cholangitis. She was admitted three days ago with a temperature of 39.2°C (102.6°F), severe right upper quadrant pain, and scleral icterus. On the day of admission, blood cultures were drawn, and she was started on empiric intravenous piperacillin-tazobactam. The following day, she underwent an urgent endoscopic retrograde cholangiopancreatography (ERCP), during which a 12-mm common bile duct stone was successfully extracted, restoring normal biliary flow. Today, the patient reports feeling significantly better and is tolerating a liquid diet. Her vital signs are a temperature of 37.0°C (98.6°F), blood pressure of 122/76 mm Hg, and pulse of 78/min. Laboratory studies show her leukocyte count has normalized to 7,500/mm³. The microbiology laboratory reports that the admission blood cultures are positive for *Escherichia coli*. The susceptibility panel confirms the isolate is resistant to ampicillin but highly susceptible to ceftriaxone, ciprofloxacin, and piperacillin-tazobactam. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Cevabı ve açıklamayı göster

Cevap: Transition to intravenous ceftriaxone

Cevap

Transition to intravenous ceftriaxone
The correct action is to transition to intravenous ceftriaxone. This patient presented with acute ascending cholangitis and appropriately received broad-spectrum empiric therapy (piperacillin-tazobactam) along with definitive source control (ERCP with stone extraction). Once clinical improvement is noted and definitive culture and susceptibility data become available, a core principle of antimicrobial stewardship is to de-escalate to the most targeted, narrow-spectrum agent that is effective against the isolated organism. Because the blood cultures grew *E. coli* that is highly susceptible to ceftriaxone, continuing the broader piperacillin-tazobactam is unnecessary and inappropriate. Targeted therapy provides excellent efficacy while minimizing the risk of multidrug-resistant organism colonization.

Adım Adım Çözüm

1
Evaluate the patient's current clinical status and interventions.
The patient is afebrile, hemodynamically stable, and has achieved definitive source control via ERCP.
Establishing clinical stability confirms that the current treatment trajectory is successful and safe for modification.
2
Analyze the microbiology and susceptibility data.
Blood cultures isolate E. coli that is susceptible to ceftriaxone, a narrower-spectrum agent than the empiric piperacillin-tazobactam.
Objective culture data provides the foundation for transitioning from empiric to targeted therapy.
3
Apply the principles of antimicrobial stewardship.
Piperacillin-tazobactam is discontinued in favor of ceftriaxone.
De-escalating to the narrowest effective agent minimizes the risk of resistance and secondary infections like Clostridioides difficile.

Anahtar Kavram

Antimicrobial Stewardship: De-escalation of antibiotics in acute cholangitis following source control and culture susceptibility results.
Sayfa 1 / 19Sonraki
Gastroenterology and Hepatology Alıştırma Soruları — USMLE Step 2 CK | Examkin